Chip Baird
Chief Executive Officer presso 2SEVENTY BIO, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
William Denise Baird is currently the Chief Executive Officer & Director at 2seventy Bio, Inc. He is also the Chairman at Deep Genomics, Inc. Mr. Baird previously served as an Independent Director at Axcella Health, Inc. from 2018 to 2023.
He was also a Director at Amicus Therapeutics UK Ltd.
Mr. Baird held the position of Chief Financial Officer at Amicus Therapeutics, Inc. from 2012 to 2018 and at PTC Therapeutics, Inc. from 2002 to 2012.
He briefly served as the Chief Financial & Accounting Officer at bluebird bio, Inc. in 2021.
Prior to that, Mr. Baird worked as an Engagement Manager at The Lek from 1999 to 2002.
He holds an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree from the Edmund A.
Walsh School of Foreign Service.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
2SEVENTY BIO, INC.
0.60% | 01/04/2024 | 308 585 ( 0.60% ) | 2 M $ | 31/03/2024 |
AXCELLA HEALTH, INC.
-.--% | 31/10/2023 | 0 ( -.--% ) | - $ | 31/12/2023 |
Posizioni attive di Chip Baird
Società | Posizione | Inizio |
---|---|---|
2SEVENTY BIO, INC. | Chief Executive Officer | - |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Chairman | 15/09/2023 |
Precedenti posizioni note di Chip Baird
Società | Posizione | Fine |
---|---|---|
AXCA HEALPAR | Director/Board Member | 01/11/2023 |
BLUEBIRD BIO, INC. | Director of Finance/CFO | 04/11/2021 |
AMICUS THERAPEUTICS, INC. | Director of Finance/CFO | 19/12/2018 |
PTC THERAPEUTICS, INC. | Director of Finance/CFO | 01/04/2012 |
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/2002 |
Formazione di Chip Baird
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Edmund A. Walsh School of Foreign Service | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
AMICUS THERAPEUTICS, INC. | Health Technology |
PTC THERAPEUTICS, INC. | Health Technology |
BLUEBIRD BIO, INC. | Health Technology |
AXCA HEALPAR | Health Technology |
2SEVENTY BIO, INC. | Health Technology |
Aziende private | 3 |
---|---|
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Commercial Services |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Health Technology |
Amicus Therapeutics UK Ltd.
Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Amicus Therapeutics, Inc., Amicus Therapeutics UK Ltd. is a private company that focuses on delivering high-quality therapies for persons living with rare and orphan diseases. The company is based in Gerrards Cross, UK. The employees of Amicus crafted a belief statement that encompasses their core values and reminds them of the reason they do what they do every day. The statement outlines the fundamental beliefs that are crucial to understanding the passion and commitment behind Amicus. The British company believes in the fight to remain at the forefront of therapies for rare and orphan diseases, supporting the disease communities and their families, and fostering teamwork and respect for each individual's contribution. | Commercial Services |
- Borsa valori
- Insiders
- Chip Baird